Featured Research

from universities, journals, and other organizations

Measuring Artificial Viruses To Improve Disease Detection

Date:
July 5, 2004
Source:
National Institute Of Standards And Technology (NIST)
Summary:
A new method developed by researchers at the National Institute of Standards and Technology (NIST) for accurately measuring the concentration of artificial viruses in a solution may ultimately help doctors diagnose diseases like HIV and hepatitis C earlier.

A new method* developed by researchers at the National Institute of Standards and Technology (NIST) for accurately measuring the concentration of artificial viruses in a solution may ultimately help doctors diagnose diseases like HIV and hepatitis C earlier.

These artificial viruses are commercial standards made from the same basic chemical components in RNA (the single stranded version of DNA needed for protein synthesis.) They are constructed to be nearly identical chemically to real viruses but are encased with a protein covering to prevent degradation. The standards are currently used in research laboratories to help check analysis methods for detecting specific types of RNA, but the product has not been approved for clinical use.

What's needed according to NIST researcher Susan Krueger is a standard, reliable way to measure the concentration of artificial RNA in solution. By knowing exactly how much of the "fake" virus is present in a patient sample, a lab can better detect any additional signal caused by real virus molecules. Traditional methods for measuring concentrations don't work well with the new product since the artificial viruses are not infectious.

Instead, NIST scientists measured the concentration of artificial RNA virus solutions using a beam of neutrons as probes. As neutrons pass through the test solution, they interact in very specific ways with particular atoms, providing scientists with detailed information on molecular weight and geometry. This information can be used to very accurately measure the amount of RNA in a given solution. Precise calibration of artificial RNA concentrations may, in turn, allow laboratories to reliably detect lower concentrations of real viruses at earlier stages of infection.

###

The NIST research was conducted in collaboration with the U.S. Army Aberdeen Proving Ground, Aberdeen, Md.

*The researchers presented their work at the second American Conference on Neutron Scattering, held June 6-10, in College Park, Md.


Story Source:

The above story is based on materials provided by National Institute Of Standards And Technology (NIST). Note: Materials may be edited for content and length.


Cite This Page:

National Institute Of Standards And Technology (NIST). "Measuring Artificial Viruses To Improve Disease Detection." ScienceDaily. ScienceDaily, 5 July 2004. <www.sciencedaily.com/releases/2004/07/040705082341.htm>.
National Institute Of Standards And Technology (NIST). (2004, July 5). Measuring Artificial Viruses To Improve Disease Detection. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2004/07/040705082341.htm
National Institute Of Standards And Technology (NIST). "Measuring Artificial Viruses To Improve Disease Detection." ScienceDaily. www.sciencedaily.com/releases/2004/07/040705082341.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins